对伴有抑制物的HA和HB患者外周血单个核细胞进行单细胞测序揭示对FVIII和FIX的不同免疫应答
研究对5例伴有抑制物的重型血友病A(HA)和5例血友病B(HB)患者的外周血单个核细胞(PBMC)进行单细胞测序,质控后共75 051个细胞聚为19个亚群。转录组分析显示两组淋巴细胞亚群组成和免疫细胞功能状态存在差异,免疫组库分析提示两组B细胞和T细胞克隆多样性不同;HA组B细胞比例较高且B细胞更活跃,HB组T细胞比例较高且CD4+辅助性T细胞更活跃。
要点
- HA组B细胞比例相对较高且B细胞更活跃,HB组T细胞比例较高且CD4+辅助性T细胞更活跃。
- 两组间淋巴细胞亚群组成、免疫细胞功能状态及B/T细胞克隆多样性存在差异。
- 该单细胞测序数据为未来研究免疫系统如何识别并启动对不同分子特征抗原的应答提供资源。
核心结论
- 对伴有抑制物的HA和HB患者PBMC的单细胞测序揭示了两者对治疗性FVIII和FIX的不同免疫应答所涉及的 distinct 生物学过程。
- 所产生的数据将作为宝贵资源,用于未来研究免疫系统如何识别并启动对不同分子特征抗原的应答。
研究设计与样本
- 对从5例伴有抑制物的HA患者和5例伴有抑制物的HB患者采集的外周血单个核细胞(PBMC)进行单细胞测序。
- 质控后共75 051个细胞聚为19个亚群。
主要发现
- 转录组分析显示HA组与HB组之间淋巴细胞亚群组成和免疫细胞功能状态存在差异。
- 免疫组库分析表明两组间B细胞和T细胞克隆多样性存在差异。
- HA组B细胞比例相对较高且B细胞更活跃,HB组T细胞比例较高且CD4+辅助性T细胞更活跃。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Inhibitors are the most severe complication of replacement therapy in patients with hemophilia. Previous studies, along with our clinical observations, have identified distinct incidence rates and clinical manifestations of factor VIII (FVIII) and FIX inhibitors in patients with severe hemophilia A (HA) and HB. To explore different immune responses to FVIII and FIX in patients with HA and HB and elucidate the mechanisms underlying the varying clinical manifestations of these patients, we performed single-cell sequencing on peripheral blood mononuclear cells (PBMCs) collected from 5 patients with HA and 5 with HB with inhibitors. After quality control, a total of 75 051 cells were clustered into 19 subsets. Transcriptome analysis revealed differences in the composition of lymphocyte subsets and the functional status of immune cells between the HA and HB groups. Additionally, immune repertoire analysis indicated variations in the diversity of B- and T-cell clones between the 2 groups. HA group exhibited a relatively higher proportion of B cells and more active B cells, whereas HB group demonstrated a higher proportion of T cells, with more active CD4+ T helper cells. Our study provides insights into the distinct biological processes underlying the distinct immune responses to therapeutic FVIII and FIX in patients with HA and HB, as revealed through single-cell sequencing of PBMCs from patients with hemophilia with inhibitors. The data generated will serve as a valuable resource for future research on how the immune system recognizes and initiates responses to antigens with varying molecular characteristics.
引用
- Li E, Li Z, Wang J, et al. Single-cell sequencing on PBMCs from patients with HA and HB with inhibitors reveals different immune responses to FVIII and FIX. Blood Adv. 2025. PMID: 40402102. doi:10.1182/bloodadvances.2025015799
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。